首页 | 本学科首页   官方微博 | 高级检索  
     检索      


New applications of the VDmax approach to substantiation of preselected sterilization doses
Authors:JB Kowalski
Institution:1. Department of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Technická 5, Prague 6, 166 28, Czech Republic;2. Department of Solid State Engineering, Institute of Chemical Technology, Prague, Technická 5, Prague 6, 166 28, Czech Republic;1. Research Unit Plasma Technology (RUPT), Department of Applied Physics, Faculty of Engineering, Ghent University, Sint-Pietersnieuwstraat 41, 9000 Ghent, Belgium;2. Department of Basic Medical Science, Faculty of Medicine and Health Science, Ghent Universtity, De Pintelaan 185 6B3, 9000 Ghent, Belgium;3. Polymer Chemistry & Biomaterials Group, Department of Organic Chemistry, Faculty of Sciences, Ghent University, Krijgslaan 281S4, 9000 Ghent, Belgium
Abstract:The VDmax approach for substantiation of 25 kGy has been in use for more than 10 years. VDmax methods are included in ISO 11137-2:2006 and AAMI TIR33:2005. ISO Technical Specification, 13004, is under development that will include sterilization doses from 15 to 35 kGy.For substantiation of a sterilization dose for very low bioburden products, less than or equal to 0.3, values of VDmax have now been derived and tabulated for a sterilization dose of 12.5 kGy.Products have been encountered that have both low bioburden and a relatively low maximum dose. In several situations, existing tabulated VDmax values could not be effectively used; in one such situation, the average bioburden was too high to substantiate a 15 kGy sterilization dose and the use of a 17.5 kGy sterilization dose was not practicable due to the likelihood of exceeding the product's maximum acceptable dose. For this product, values of VDmax were derived and tabulated for substantiation of a 16.1 kGy sterilization dose.Values of VDmax have been derived and tabulated for the substantiation of sterilization doses linked to a sterility assurance level (SAL) of 10?3. To offer a potential alternative to aseptic processing, the notion of using an “aseptic processing equivalent dose”, 10?4 SAL, has been investigated along with the use of alternate model populations for calculation of VDmax values.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号